ロード中...
Clinical characteristics and PD-L1 expression in primary lung squamous cell carcinoma: A case series
BACKGROUND: Squamous cell lung carcinoma(SCLC), accounts for 20% of lung cancer(LC). The binding of programmed cell death 1(PD-1) to its ligand PD-L1 is a key checkpoint regulator of immune response, and overexpression of the latter leads to immune surveillance escape. This might represent an import...
保存先:
| 出版年: | Respir Med Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7287140/ https://ncbi.nlm.nih.gov/pubmed/32551224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101114 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|